I have bought in today - one of the reasons I bought is I wanted a biotech as sold out of NAN.
COH is expensive on paper but hasnt been slammed into oblivion. I think the issues COH is facing are not structural problems. I have gone through the financials and read several reports will be happy to ride this one out till FY21 result and act on guidance or if $250 is traded before then whichever comes first.
$200, page-7
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add COH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$337.54 |
Change
3.700(1.11%) |
Mkt cap ! $22.10B | |||
| Open | High | Low | Value | Volume |
| $335.73 | $340.34 | $334.00 | $31.76M | 94.05K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 775 | $337.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $338.42 | 122 | 1 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| COH (ASX) Chart |